Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Valutazione clinica della sicurezza e dell'efficacia del sistema NEUROMARK nei soggetti con rinite cronica (PARAGON)

16 ottobre 2026 aggiornato da: Neurent Medical

Valutazione clinica della sicurezza e dell'efficacia del sistema NEUROMARK in soggetti con rinite cronica (PARAGON) - Uno studio clinico prospettico, a braccio singolo e multicentrico.

The PARAGON Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Effettivo)

80

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Alabama
      • Birmingham, Alabama, Stati Uniti, 35242
        • Alabama Nasal and Sinus Center (Alabama Allergy)
    • California
      • California City, California, Stati Uniti, 95661
        • Sacramento ENT
      • Temecula, California, Stati Uniti, 92592
        • United Medical Doctors
    • Colorado
      • Colorado Springs, Colorado, Stati Uniti, 80923
        • Colorado ENT
    • Louisiana
      • Marrero, Louisiana, Stati Uniti, 70072
        • New Orleans Sinus Center
    • Maryland
      • Baltimore, Maryland, Stati Uniti, 21204
        • Centers for Advanced ENT Care (CAdENT)
    • Michigan
      • Royal Oak, Michigan, Stati Uniti, 48073
        • Rontal Clinics
    • Pennsylvania
      • Bethlehem, Pennsylvania, Stati Uniti, 18017
        • Specialty Physician Associates
    • Virginia
      • Richmond, Virginia, Stati Uniti, 23235
        • Richmond ENT
    • Washington
      • Seattle, Washington, Stati Uniti, 98374-1145
        • Ear Nose Throat & Allergy Associates

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

Subjects MUST:

  1. Be ≥18 years of age.
  2. Have been experiencing rhinitis symptoms for a minimum of 6 months.
  3. Have moderate to severe symptoms of runny nose (individual rTNSS symptom rating of 2 or 3), mild to severe symptoms of nasal congestion (individual rTNSS symptom rating of 1,2, or 3), and a minimum total score of 5 (out of 12) at baseline.
  4. Have an allergy test (by skin prick or intradermal testing, or by a validated in vitroImmunoglobin E [IgE test]) on file within 5 years of the baseline visit or is willing to have one performed during the study prior to 6-month visit.
  5. Be an appropriate candidate for bilateral NEUROMARK® device treatment performed under local anesthesia.
  6. Test negative for active COVID-19 at the start of the study screening and continue to be free of COVID-19 symptoms until the time of enrollment/treatment.
  7. Be willing and able to comply with all study elements, as indicated by written informed consent.

Exclusion Criteria:

Subjects MUST NOT:

  1. Have clinically significant anatomic obstruction that in the investigator's opinion limit access to the posterior nose, including but not limited to severe septal deviation or perforation, nasal polyps, and/or sinonasal tumor.
  2. Have had previous sinus or nasal surgery within 6 months of study enrollment.
  3. Have previously undergone RF, cryotherapy, or other surgical interventions for rhinitis.
  4. Have an active nasal or sinus infection.
  5. Have nasal mucosal erosion/ulceration.
  6. Have rhinitis symptoms that are due to seasonal allergies only.
  7. Have plans to (or otherwise anticipates the need to) undergo an ENT procedure concurrently or within 6 months after the study procedure.
  8. Have started a new sinonasal medication regimen within 4 weeks prior to treatment that, according to the manufacturer's labelling, has not yet stabilized.
  9. Be on prescribed anticoagulants (eg, warfarin, Plavix) or ≥ 325 mg aspirin that cannot be held for an appropriate time before the procedure.
  10. Have a history of chronic epistaxis or experienced a significant epistaxis event (defined as epistaxis requiring medical intervention) in the past 3 months.
  11. Have numbness of the soft palate, excessive dry eye, excessive dry nose, or other indication of neuro/nerve compromise in the sinonasal cavity.
  12. Have an active rhinitis medicamentosa or a history of rhinitis medicamentosa within the past 6 months.
  13. Have been diagnosed with atrophic rhinitis.
  14. Have had previous head and/or neck irradiation.
  15. Have an allergy or intolerance to local anesthetic agents.
  16. Be pregnant.
  17. Have a physical, neurological, medical, psychiatric condition or situation that, in the investigator's opinion, puts the subject at risk, could confound the study results, or may interfere significantly with the subject's participation in the study.
  18. Be participating in another clinical research study.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Treatment

Subjects will undergo treatment with the NEUROMARK System

The NEUROMARK System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Total rTNSS Score 6M
Lasso di tempo: 6-Month Follow Up

Change in total rTNSS score from baseline at 6-Month Follow up. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

6-Month Follow Up
Device- and/or Procedure-related SAEs
Lasso di tempo: 24-Month Follow Up

Number of participants who experienced a device- and/or procedure-related serious adverse event during the course of the study.

24-Month Follow Up

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Total rTNSS Score 1M
Lasso di tempo: 1-Month Follow Up

Change in total rTNSS score from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

1-Month Follow Up
Total rTNSS Score 3M
Lasso di tempo: 3-Month Follow Up

Change in total rTNSS score from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

3-Month Follow Up
Total rTNSS Score 9M
Lasso di tempo: 9-Month Follow Up

Change in total rTNSS score from baseline at 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

9-Month Follow Up
Total rTNSS Score 12M
Lasso di tempo: 12-Month Follow Up

Change in total rTNSS score from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

12-Month Follow Up
Total rTNSS Score 15M
Lasso di tempo: 15-Month Follow Up

Change in total rTNSS score from baseline at 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

15-Month Follow Up
Total rTNSS Score 18M
Lasso di tempo: 18-Month Follow Up

Change in total rTNSS score from baseline at 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

18-Month Follow Up
Total rTNSS Score 21M
Lasso di tempo: 21-Month Follow Up

Change in total rTNSS score from baseline at 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

21-Month Follow Up
Total rTNSS Score 24M
Lasso di tempo: 24-Month Follow Up

Change in rTNSS score from baseline at the final 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

24-Month Follow Up
rTNSS Congestion Score 1M
Lasso di tempo: 1-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

1-Month Follow Up
rTNSS Rhinorrhea Score 1M
Lasso di tempo: 1-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

1-Month Follow Up
rTNSS Nasal Itching Score 1M
Lasso di tempo: 1-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

1-Month Follow Up
rTNSS Sneezing Score 1M
Lasso di tempo: 1-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

1-Month Follow Up
rTNSS Congestion Score 3M
Lasso di tempo: 3-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

3-Month Follow Up
rTNSS Rhinorrhea Score 3M
Lasso di tempo: 3-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

3-Month Follow Up
rTNSS Nasal Itching Score 3M
Lasso di tempo: 3-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

3-Month Follow Up
rTNSS Sneezing Score 3M
Lasso di tempo: 3-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

3-Month Follow Up
rTNSS Congestion Score 6M
Lasso di tempo: 6-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 6-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

6-Month Follow Up
rTNSS Rhinorrhea Score 6M
Lasso di tempo: 6-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 6-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

6-Month Follow Up
rTNSS Nasal Itching Score 6M
Lasso di tempo: 6-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 6-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

6-Month Follow Up
rTNSS Sneezing Score 6M
Lasso di tempo: 6-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 6-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

6-Month Follow Up
rTNSS Congestion Score 9M
Lasso di tempo: 9-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

9-Month Follow Up
rTNSS Rhinorrhea Score 9M
Lasso di tempo: 9-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

9-Month Follow Up
rTNSS Nasal Itching Score 9M
Lasso di tempo: 9-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

9-Month Follow Up
rTNSS Sneezing Score 9M
Lasso di tempo: 9-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

9-Month Follow Up
rTNSS Congestion Score 12M
Lasso di tempo: 12-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

12-Month Follow Up
rTNSS Rhinorrhea Score 12M
Lasso di tempo: 12-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

12-Month Follow Up
rTNSS Nasal Itching Score 12M
Lasso di tempo: 12-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

12-Month Follow Up
rTNSS Sneezing Score 12M
Lasso di tempo: 12-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

12-Month Follow Up
rTNSS Congestion Score 15M
Lasso di tempo: 15-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

15-Month Follow Up
rTNSS Rhinorrhea Score 15M
Lasso di tempo: 15-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

15-Month Follow Up
rTNSS Nasal Itching Score 15M
Lasso di tempo: 15-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

15-Month Follow Up
rTNSS Sneezing Score 15M
Lasso di tempo: 15-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

15-Month Follow Up
rTNSS Congestion Score 18M
Lasso di tempo: 18-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

18-Month Follow Up
rTNSS Rhinorrhea Score 18M
Lasso di tempo: 18-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

18-Month Follow Up
rTNSS Nasal Itching Score 18M
Lasso di tempo: 18-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

18-Month Follow Up
rTNSS Sneezing Score 18M
Lasso di tempo: 18-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

18-Month Follow Up
rTNSS Congestion Score 21M
Lasso di tempo: 21-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

21-Month Follow Up
rTNSS Rhinorrhea Score 21M
Lasso di tempo: 21-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

21-Month Follow Up
rTNSS Nasal Itching Score 21M
Lasso di tempo: 21-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

21-Month Follow Up
rTNSS Sneezing Score 21M
Lasso di tempo: 21-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

21-Month Follow Up
rTNSS Congestion Score 24M
Lasso di tempo: 24-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

24-Month Follow Up
rTNSS Rhinorrhea Score 24M
Lasso di tempo: 24-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

24-Month Follow Up
rTNSS Nasal Itching Score 24M
Lasso di tempo: 24-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

24-Month Follow Up
rTNSS Sneezing Score 24M
Lasso di tempo: 24-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

24-Month Follow Up
Total Mini-RQLQ Score 3M
Lasso di tempo: 3-Month Follow Up

Change in total mini-RQLQ score from baseline at the 3-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score.

3-Month Follow Up
Total Mini-RQLQ Score 6M
Lasso di tempo: 6-Month Follow Up

Change in total mini-RQLQ score from baseline at the 6-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score.

6-Month Follow Up
Total Mini-RQLQ Score 12M
Lasso di tempo: 12-Month Follow Up

Change in total mini-RQLQ score from baseline at the 12-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score.

12-Month Follow Up
Total Mini-RQLQ Score 18M
Lasso di tempo: 18-Month Follow Up

Change in total mini-RQLQ score from baseline at the 18-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score.

18-Month Follow Up
Total Mini-RQLQ Score 21M
Lasso di tempo: 21-Month Follow Up

Change in total mini-RQLQ score from baseline at the 21-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score.

21-Month Follow Up
Total Mini-RQLQ Score 24M
Lasso di tempo: 24-Month Follow Up

Change in total mini-RQLQ score from baseline at the 24-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score.

24-Month Follow Up

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Direttore dello studio: Annalise Sorensen, Neurent Medical

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

26 settembre 2022

Completamento primario (Effettivo)

5 agosto 2025

Completamento dello studio (Effettivo)

5 agosto 2025

Date di iscrizione allo studio

Primo inviato

18 ottobre 2022

Primo inviato che soddisfa i criteri di controllo qualità

20 ottobre 2022

Primo Inserito (Effettivo)

24 ottobre 2022

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

10 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

16 ottobre 2026

Ultimo verificato

1 ottobre 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Altri numeri di identificazione dello studio

  • CIP-0007

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

Sì

prodotto fabbricato ed esportato dagli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi